Study to Evaluate Safety, Efficacy and Tolerability of Clobetasol Propionate for Chronic Hand Dermatitis

Stiefel

Status and phase: Completed; Phase 4

Conditions: Hand Dermatosis

Treatments: Drug: clobetasol propionate

Study type: Interventional

Funder types: Industry

Identifiers

NCT00828464

U0280-401

Details and patient eligibility

About

The purpose of the study is to assess the safety, efficacy and tolerability of Clobetasol propionate foam in subjects with chronic dermatitis.

Full description

The study is being conducted in order to obtain safety, efficacy and tolerability data for Clobetasol propionate foam in the treatment of chronic dermatitis. The subjects must have mild to moderate disease based on the Investigator's assessment at baseline.

Enrollment: 30 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Subjects 18 years of age or older, with diagnosis of chronic dermatitis, able to complete the study and comply with study instructions.
• Female subjects of childbearing potential must have a negative pregnancy test. Sexually active women of childbearing potential participating in the study must have been using a medically acceptable form of contraception

Exclusion criteria

• Use of systemic corticosteroid and/or other prohibited medications within 4 weeks of the baseline visit.
• Use of topical corticosteroid therapy and/or other prohibited topical medications within 2 weeks prior to the baseline visit

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

30 participants in 1 patient group

clobetasol propionate foam

Experimental group

Description:

All subjects receive clobetasol propionate

Treatment:

Drug: clobetasol propionate